z-logo
Premium
Absence of SCL mutations in myeloid malignancies
Author(s) -
Delabesse Eric,
Li Juan,
Schnittger Susanne,
Hiddemann Wolfgang,
Green Anthony R.
Publication year - 2003
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2003.04122.x
Subject(s) - medicine , myeloid , mutation , cancer research , oncology , immunology , genetics , biology , gene
Summary. Transcription factors play a central role in the pathogenesis of acute leukaemia. Genes encoding transcription factors are frequently perturbed by chromosome rearrangements. More recently acquired point mutations have been described in a number of important genes for normal haematopoiesis. The stem cell leukaemia ( SCL ) gene encodes a basic helix–loop–helix transcription factor and is upregulated by chromosome rearrangements in T‐acute lymphoblastic leukaemia. SCL function is essential for the development of both primitive and definitive haematopoiesis. We searched for SCL mutations in myeloid leukaemias and chronic myeloproliferative disorders. Our data demonstrated that SCL point mutations were rare in acute myeloid leukaemia and myeloproliferative disorders.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here